Pharmidex delighted to meet with US Congressional Representative Scott Peters
October 28, 2017
Pharmidex delighted to meet with Congressional Representative Scott Peters and a delegation of San Diego, California's top business, civic and academic leaders in London.
17 October 2017 Pharmidex was delighted to be invited to a reception with United States Congressional Representative Scott Peters and a delegation of San Diego, California's top business, civic and academic leaders in London.
With thriving respective tech scenes, growing biotech industries and home to some of the world's best universities, London and San Diego are privileged to be known as two of the world's "smartest cities". Pharmidex has had a long interest in California as our first out of UK business development office was based at Sorrento Valley in San Diego.
We’re excited to share that Ash Alavijeh , our Head of Operations, will attend the Swiss Biotech Day 2025 on May 5–6 at the Congress Center Basel, Switzerland! 🔗 https://swissbiotechday.ch Ash looks forward to connecting with attendees to explore new collaborations and drive drug discovery and development forward. If you're in Basel, let's meet and discuss how we can advance the next wave of innovative therapies together.
We are pleased to announce that Martin Barrett , our Head of Business Development, will be attending the Making & Distributing Pharmaceuticals UK event on 29–30 April 2025 at the Coventry Building Society Arena! 🔗 ( https://lnkd.in/gd73pvE ) Martin would be delighted to meet with fellow attendees to discuss new collaboration opportunities and how we can work together to advance the development of innovative drug candidates. If you are attending, don’t miss the chance to connect with us and explore how we can drive pharmaceutical progress forward together!
We’re excited that Ash Alavijeh , our Head of Operations, will attend the Biotech Matchmaking Event on 29 April 2025 at the Old Divinity School, St John’s College, Cambridge. 🔗 (Biotech Matchmaking Event - The Milner Therapeutics Institute) Ash looks forward to meeting attendees, discussing new collaborations, and driving forward the development of innovative drug candidates. If you're attending, let’s connect and explore new opportunities together!
